Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Cameron

Showing results (1611-1620 of 1,688) with videos related to

Pageof 169
Sort By:
The New England Journal of Medicine|June 14, 2023
Prehospital Tranexamic Acid for Severe Trauma, Russell L Gruen, Biswadev Mitra, et al.
Atherosclerosis|September 17, 2025
Lipoprotein(a) concentrations and secondary outcomes following first-time acute coronary syndrome: The Multi-Ethnic New Zealand Study of Acute Coronary Syndromes (MENZACS)Malcolm E Legget, Nikki J Earle, Katrina K Poppe, et al.
Journal of the National Cancer Institute|October 18, 2024
Validation of a breast cancer assay for radiotherapy omission: an individual participant data meta-analysisPer Karlsson, Anthony Fyles, S Laura Chang, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|January 12, 2023
Impact of Anti-HER2 Therapy Alone and With Weekly Paclitaxel on the Ovarian Reserve of Young Women With HER2-Positive Breast CancerMatteo Lambertini, Marcello Ceppi, Richard A Anderson, et al.
European Journal of Cancer (Oxford, England : 1990)|July 1, 1997
CHOP-based chemotherapy is as effective as alternating PEEC/CHOP chemotherapy in a randomised trial in high-grade non-Hodgkin's lymphoma. Scotland and Newcastle Lymphoma GroupD A Cameron, J M White, S J Proctor, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 24, 2021
Niraparib for Advanced Breast Cancer with Germline <i>BRCA1</i> and <i>BRCA2</i> Mutations: the EORTC 1307-BCG/BIG5-13/TESARO PR-30-50-10-C BRAVO StudyNicholas C Turner, Judith Balmaña, Coralie Poncet, et al.
Journal of Neurotrauma|December 20, 2023
The Australian Traumatic Brain Injury Initiative: Systematic Review of Predictive Value of Biological Markers for People With Moderate-Severe Traumatic Brain InjuryMatthew K Bagg, Sarah C Hellewell, Jemma Keeves, et al.
Lancet (London, England)|June 11, 2019
6 versus 12 months of adjuvant trastuzumab for HER2-positive early breast cancer (PERSEPHONE): 4-year disease-free survival results of a randomised phase 3 non-inferiority trialHelena M Earl, Louise Hiller, Anne-Laure Vallier, et al.
Journal of the National Cancer Institute|November 9, 2014
Maastricht Delphi consensus on event definitions for classification of recurrence in breast cancer researchMartine Moossdorff, Lori M van Roozendaal, Luc J A Strobbe, et al.
Journal of Neurotrauma|December 10, 2015
Early Decompression following Cervical Spinal Cord Injury: Examining the Process of Care from Accident Scene to SurgeryCamila R Battistuzzo, Alex Armstrong, Jillian Clark, et al.
Pageof 169

Showing results (1611-1620 of 1,688) with videos related to

Sort By:
Pageof 169
The New England Journal of Medicine|June 14, 2023
Prehospital Tranexamic Acid for Severe Trauma, Russell L Gruen, Biswadev Mitra, et al.
Atherosclerosis|September 17, 2025
Lipoprotein(a) concentrations and secondary outcomes following first-time acute coronary syndrome: The Multi-Ethnic New Zealand Study of Acute Coronary Syndromes (MENZACS)Malcolm E Legget, Nikki J Earle, Katrina K Poppe, et al.
Journal of the National Cancer Institute|October 18, 2024
Validation of a breast cancer assay for radiotherapy omission: an individual participant data meta-analysisPer Karlsson, Anthony Fyles, S Laura Chang, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|January 12, 2023
Impact of Anti-HER2 Therapy Alone and With Weekly Paclitaxel on the Ovarian Reserve of Young Women With HER2-Positive Breast CancerMatteo Lambertini, Marcello Ceppi, Richard A Anderson, et al.
European Journal of Cancer (Oxford, England : 1990)|July 1, 1997
CHOP-based chemotherapy is as effective as alternating PEEC/CHOP chemotherapy in a randomised trial in high-grade non-Hodgkin's lymphoma. Scotland and Newcastle Lymphoma GroupD A Cameron, J M White, S J Proctor, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 24, 2021
Niraparib for Advanced Breast Cancer with Germline <i>BRCA1</i> and <i>BRCA2</i> Mutations: the EORTC 1307-BCG/BIG5-13/TESARO PR-30-50-10-C BRAVO StudyNicholas C Turner, Judith Balmaña, Coralie Poncet, et al.
Journal of Neurotrauma|December 20, 2023
The Australian Traumatic Brain Injury Initiative: Systematic Review of Predictive Value of Biological Markers for People With Moderate-Severe Traumatic Brain InjuryMatthew K Bagg, Sarah C Hellewell, Jemma Keeves, et al.
Lancet (London, England)|June 11, 2019
6 versus 12 months of adjuvant trastuzumab for HER2-positive early breast cancer (PERSEPHONE): 4-year disease-free survival results of a randomised phase 3 non-inferiority trialHelena M Earl, Louise Hiller, Anne-Laure Vallier, et al.
Journal of the National Cancer Institute|November 9, 2014
Maastricht Delphi consensus on event definitions for classification of recurrence in breast cancer researchMartine Moossdorff, Lori M van Roozendaal, Luc J A Strobbe, et al.
Journal of Neurotrauma|December 10, 2015
Early Decompression following Cervical Spinal Cord Injury: Examining the Process of Care from Accident Scene to SurgeryCamila R Battistuzzo, Alex Armstrong, Jillian Clark, et al.
Pageof 169